250 related articles for article (PubMed ID: 9240634)
1. Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer--results from a Phase I trial.
Hoffmann W; Belka C; Schmidberger H; Budach W; Bochtler H; Hess CF; Bamberg M
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):691-6. PubMed ID: 9240634
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of weekly docetaxel infusion and concurrent radiation therapy for head and neck cancer.
Suzuki M; Nishimura Y; Nakamatsu K; Kanamori S; Koike R; Kawamoto M; Mori K
Jpn J Clin Oncol; 2003 Jun; 33(6):297-301. PubMed ID: 12913084
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy concurrent with weekly paclitaxel for locoregionally advanced nasopharyngeal carcinoma: outcomes of a phase I trial.
Chen M; Wu SX; Chen YY; Lu LX; Bao Y; Lin HX; Xian CG; Li Q; Deng XW; Lu TX; Cui NJ
Am J Clin Oncol; 2004 Oct; 27(5):481-4. PubMed ID: 15596915
[TBL] [Abstract][Full Text] [Related]
4. A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer.
Machtay M; Aviles V; Kligerman MM; Treat J; Weinstein GS; Weber RS; Mirza N; Chalian AA; Rosenthal DI
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):311-5. PubMed ID: 10760424
[TBL] [Abstract][Full Text] [Related]
5. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy to weekly paclitaxel concurrent with curative radiotherapy in stage IV (M0) unresectable head and neck squamous cell carcinoma: a dose escalation study.
Pergolizzi S; Adamo V; Ferraro G; Sergi C; Santacaterina A; Romeo A; De Renzis C; Zanghì M; Rossello R; Settineri N
J Chemother; 2004 Apr; 16(2):201-5. PubMed ID: 15216957
[TBL] [Abstract][Full Text] [Related]
7. Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers.
Dowell JE; Sinard R; Yardley DA; Aviles V; Machtay M; Weber RS; Weinstein GS; Chalian AA; Carbone DP; Rosenthal DI
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):97-101. PubMed ID: 10210547
[TBL] [Abstract][Full Text] [Related]
8. A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.
Tishler RB; Norris CM; Colevas AD; Lamb CC; Karp D; Busse PM; Nixon A; Frankenthaler R; Lake-Willcutt B; Costello R; Case M; Posner MR
Cancer; 2002 Oct; 95(7):1472-81. PubMed ID: 12237916
[TBL] [Abstract][Full Text] [Related]
9. [Weekly paclitaxel with concurrent intensity-modulated radiotherapy for nasopharyngeal carcinoma: outcomes of a tolerance trial].
Chen CY; Lu TX; Zhao C; Lu LX; Han F; Sun Y
Ai Zheng; 2007 Apr; 26(4):398-402. PubMed ID: 17430660
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
[TBL] [Abstract][Full Text] [Related]
11. Combined irinotecan, docetaxel and conventionally fractionated radiotherapy in locally advanced head and neck cancer. A phase I dose escalation study.
Koukourakis MI; Bizakis JG; Skoulakis CE; Kyrmizakis D; Giatromanolaki A; Papadakis CE; Prokopakis E; Amanakis Z; Hellidonis ES
Anticancer Res; 1999; 19(3B):2305-9. PubMed ID: 10472349
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of paclitaxel administered by ten-day continuous infusion.
Shade RJ; Pisters KM; Huber MH; Fossella F; Perez-Soler R; Shin DM; Kurie J; Glisson B; Lippman S; Lee JS
Invest New Drugs; 1998-1999; 16(3):237-43. PubMed ID: 10360603
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).
Fury MG; Sherman EJ; Rao SS; Wolden S; Smith-Marrone S; Mueller B; Ng KK; Dutta PR; Gelblum DY; Lee JL; Shen R; Kurz S; Katabi N; Haque S; Lee NY; Pfister DG
Ann Oncol; 2014 Mar; 25(3):689-694. PubMed ID: 24496920
[TBL] [Abstract][Full Text] [Related]
14. Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I study.
Gridelli C; Guida C; Barletta E; Gatani T; Fiore F; Barzelloni ML; Rossi A; de Bellis M; D'Aniello R; Scognamiglio F
Lung Cancer; 2000 Aug; 29(2):131-7. PubMed ID: 10963843
[TBL] [Abstract][Full Text] [Related]
15. Weekly gemcitabine and cisplatin in combination with radiotherapy in patients with locally advanced head-and-neck cancer: Phase I study.
Viani GA; Afonso SL; Tavares VC; da Silva LG; Stefano EJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e231-5. PubMed ID: 21570216
[TBL] [Abstract][Full Text] [Related]
16. Final report of a pilot trial of accelerated radiotherapy plus concurrent 96-hour infusional paclitaxel for locally advanced head and neck cancer.
Bucci MK; Rosenthal DI; Hershock D; Metz J; Devine P; Kligerman MM; Machtay M
Am J Clin Oncol; 2004 Dec; 27(6):595-602. PubMed ID: 15577438
[TBL] [Abstract][Full Text] [Related]
17. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of weekly docetaxel and concurrent radiotherapy for head and neck cancer in elderly patients or patients with complications.
Kodaira T; Fuwa N; Furutani K; Tachibana H; Yamazaki T
Jpn J Clin Oncol; 2005 Apr; 35(4):173-6. PubMed ID: 15845564
[TBL] [Abstract][Full Text] [Related]
19. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
Choy H; Yee L; Cole BF
Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
[TBL] [Abstract][Full Text] [Related]
20. Phase I study to determine the MTD of paclitaxel given three times per week during concurrent radiation therapy for stage III non-small cell lung cancer.
Shi A; An T; Zhu G; Yu R; Xu G; Liu X; Xu B
Curr Med Res Opin; 2007 May; 23(5):1161-7. PubMed ID: 17519083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
